U.S. approval of pharma companies' COVID-19 vaccine development handling 2021

Percentage of U.S. adults who approve of how pharmaceutical companies handled COVID-19 vaccine development as of 2021

Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

April 2021

Region

United States

Survey time period

March 24-26, 2021

Number of respondents

1,225 respondents

Age group

18 years and older

Special properties

likely voters

Method of interview

Online survey

Supplementary notes

Original question: "Do you approve or disapprove of how pharmaceutical companies like Pfizer, Moderna, and Johnson & Johnson handled vaccine development in response to the pandemic?"

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,148 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD $179 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " U.S. pharmaceutical industry "

Other statistics that may interest you U.S. pharmaceutical industry

Contribution to global pharma

5

Overview

6

Companies

6

Research and development

7

Generics

5

Public view on pharma

6

Outlook

4

Further related statistics

18
Statista Accounts: Access All Statistics. Starting from $2,148 USD / Year
Learn more about how Statista can support your business.